28th - 30th June, 2021

4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition (Time Zone - EST)

Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress-US Edition to be held on 28th-30th June 2021 would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.

WHAT TO EXPECT
Key Highlights
  • Updates in development of ADC’s and Bispecific Ab’s
  • Immune Checkpoint Inhibitors and Combinations
  • Biomarkers and Cancer Vaccines
  • CAR-T cell therapy, T-Cell Therapy
  • Tumor microenvironment
  • Oncolytic Viruses
  • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators)
Who Should Attend?

CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group Leaders, Professors, Assistant Professors, Research fellows, PhDs working on

  • Monoclonal and Bispecific Antibodies
  • Cell Therapy
  • Immune Checkpoint Inhibitors
Why Attend?
  • Exclusive conference to learn about antibodies, cellular therapy and immune-checkpoint research under one roof
  • Find out new case studies of immune-oncology projects in development
  • Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
  • Explore the latest platforms and technologies on the market for development
  • Discuss the best tool for your research in immune-oncology
  • Share your work and achievements with your industry peers in the Poster Sessions 
CONFERENCE AGENDA
CELLULAR THERAPY, PERSONALIZED IMMUNOTHERAPY, VACCINES AND ONCOLYTIC VIRAL THERAPY
CONFERENCE SPEAKERS
Speakers
Pamela Reilly Contag

Pamela Reilly Contag

CEO
BioEclipse Therapeutics

Pamela Reilly Contag

CEO
BioEclipse Therapeutics
Laura Codarri Deak

Laura Codarri Deak

Principal Scientist, Team Leader
Cancer Immunotherapy, Roche

Laura Codarri Deak

Principal Scientist, Team Leader
Cancer Immunotherapy, Roche
Mark Exley

Mark Exley

Chief Scientific Officer
ImVax

Mark Exley

Chief Scientific Officer
ImVax
Sari Pesonen

Sari Pesonen

Co-Founder, Head, R&D
Valo Therapeutics

Sari Pesonen

Co-Founder, Head, R&D
Valo Therapeutics
Stephen Schoenberger

Stephen Schoenberger

Professor, Center for Cancer Immunotherapy
La Jolla University

Stephen Schoenberger

Professor, Center for Cancer Immunotherapy
La Jolla University
Juan Perez Villar

Juan Perez Villar

CEO
LeadArtis

Juan Perez Villar

CEO
LeadArtis
Stefan Glueck

Stefan Glueck

Senior Vice President, Global Medical Affairs
Celgene

Stefan Glueck

Senior Vice President, Global Medical Affairs
Celgene
William Williams

William Williams

President, CEO
Briacell Therapeutics Corporation

William Williams

President, CEO
Briacell Therapeutics Corporation
SPONSORS
Gold
example-image

BIOCYTOGEN

example-image

Applied BioMath

PARTNERS
Media Partners
example-image

PharmaVOICE

example-image

PharmaTutor

example-image

Pharma Journalist

PAST EVENT GALLERY